|                                |
|--------------------------------|
|                                |  |
| Media Contact                  | February 19, 2014 |
| Casey Lassiter, 205-410-2777   | For Immediate Release |
| casey.lassiter@healthsouth.com |   |
|                           |   |
| Investor Relations Contact     |   |
| Mary Ann Arico, 205-969-6175   |   |
| maryann.arico@healthsouth.com  |   |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Consolidated net operating revenues were $572.1 million for the fourth quarter of 2013 compared to $552.9 million for the fourth quarter of 2012, or an increase of 3.5%. This increase was attributable to a 3.8% increase in patient discharges offset by a 0.1% decrease in net patient revenue per discharge. Discharge growth included a 1.3% increase in same-store discharges. Same-store discharges in the fourth quarter of 2013 were negatively impacted by the divestiture of 41 skilled nursing facility beds in the first quarter of 2013. Net patient revenue per discharge was negatively impacted in the fourth quarter of 2013 by approximately $9 million for sequestration and approximately $8 million for contractual allowances related to Recovery Audit Contractor (“RAC”) audits. As disclosed previously, and in connection with CMS approved and announced RAC audits related to inpatient rehabilitation facilities, the Company received requests in 2013 to review certain patient files for discharges occurring from 2010 to 2013. To date, the Medicare payments that are subject to these audit requests represent less than 1% of the Company's Medicare patient discharges during those years, and not all of these patient file requests have resulted in payment denial determinations by the RACs. In the fourth quarter of 2013, the Company reduced its net operating revenues by approximately $8 million to establish reserves for post-payment claims that are part of RAC audits. Concurrently, the Company reversed approximately $4 million in bad debt reserves established during 2013 related to RAC audits. Excluding the negative impact of sequestration and reserves related to RAC audits, net patient revenue per discharge would have increased by 3.2%. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Income from continuing operations attributable to HealthSouth per basic share for the fourth quarter of 2013 was $(0.31) compared to $0.41 for the same period of 2012. Earnings per share for the fourth quarter of 2013 benefited from solid operating results offset by the $71.6 million, or $(0.83) per share, repurchase premium associated with the exchange transactions involving the Company's convertible perpetual preferred stock. In |

|        |
|--------|
|        |  |  |
|   |   | 1 |

----

|         |                                                                                                                                                                                                                                         |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Cash flows provided by operating activities were $100.9 million for the fourth quarter of 2013 compared to $109.3 million for the fourth quarter of 2012. This decrease primarily resulted from an increase in working capital. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted EBITDA (see attached supplemental information) for the fourth quarter of 2013 was $142.3 million compared to $128.6 million for the fourth quarter of 2012, or an increase of 10.7%. This improvement was primarily due to continued revenue growth, disciplined expense management, and a reduction in self-insurance reserves. As a result of enhancements in the way the Company manages its risks, the accumulation of additional historical data, and continued favorable trends in self-insured claims, the Company lowered the statistical confidence level used to determine its self-insurance reserves in the fourth quarter of 2013. This change in estimate increased Adjusted EBITDA by $6.7 million. Adjusted EBITDA in the fourth quarter of 2013 was negatively impacted by approximately $8 million due to sequestration and approximately $4 million, on a net basis, for reserves related to RAC audits. |

|         |                                                                                                                                                                                                                                                                                                                                                                         |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted free cash flow (see attached supplemental information) for the fourth quarter of 2013 was $66.3 million compared to $81.2 million for the fourth quarter of 2012. Adjusted free cash flow in the fourth quarter of 2013 benefited from higher Adjusted EBITDA offset by increased maintenance capital expenditures and an increase in working capital. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Consolidated net operating revenues were $2,273.2 million for 2013 compared to $2,161.9 million for 2012, or an increase of 5.1%. This increase was attributable to a 5.0% increase in patient discharges and a 0.9% increase in net patient revenue per discharge. Discharge growth included a 2.5% increase in same-store discharges. Same-store discharges were negatively impacted by the divestiture of 41 skilled nursing facility beds in the first quarter of 2013. Approximately 60 basis points of discharge growth from new stores resulted from the consolidation of St. Vincent Rehabilitation Hospital beginning in the third quarter of 2012. Net patient revenue per discharge was negatively impacted in 2013 by sequestration, the impact of reserves related to RAC audits, and the ramping up of three new hospitals. As discussed above, the Company reduced its net operating revenues by approximately $8 million to establish reserves for RAC audits in 2013. |

|         |                                                                                                                                                                                                                                                         |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Income from continuing operations attributable to HealthSouth per basic share for 2013 was $2.59 compared to $1.62 for 2012. Earnings per share in 2013 was impacted by four items having a net, favorable after-tax impact of $0.84 per share: |

|         |                         |
|---------|-------------------------|
| ◦ | Positively impacted by: |

|         |                                                                                                        |
|---------|--------------------------------------------------------------------------------------------------------|
| ▪ | An approximate $115 million settlement with the Internal Revenue Service in the second quarter of 2013 |

|         |                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------|
| ▪ | The repurchase of approximately 9.1 million shares through a common stock tender offer in the first quarter of 2013 |

|         |                                                                                                                                                             |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ▪ | A reduction in certain nonrecurring expenses primarily related to government, class action, and related settlements (see attached supplemental information) |

|         |                         |
|---------|-------------------------|
| ◦ | Negatively impacted by: |

|         |                                                                                                                                     |
|---------|-------------------------------------------------------------------------------------------------------------------------------------|
| ▪ | The $71.6 million repurchase premium on the preferred stock included in the November 2013 exchange transactions, as discussed above |

|        |
|--------|
|        |  |  |
|   |   | 2 |

----

|         |                                                                                                                                                                                                                                         |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Cash flows provided by operating activities were $470.3 million for 2013 compared to $411.5 million for 2012. This increase was due primarily to increased net operating revenues and continued disciplined expense management. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted EBITDA (see attached supplemental information) for 2013 was $551.6 million compared to $505.9 million for 2012, or an increase of 9.0%. Growth in Adjusted EBITDA was due primarily to revenue growth and disciplined expense management. Adjusted EBITDA for 2013 benefited from $6.7 million of adjustments to self-insurance reserves resulting from the lowering of the statistical confidence level, as discussed above. Sequestration and reserves related to RAC audits negatively impacted Adjusted EBITDA by approximately $25 million and $8 million, respectively, during 2013. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted free cash flow (see attached supplemental information) for 2013 was $330.9 million compared to $268.0 million for 2012, or an increase of 23.5%. This increase primarily resulted from higher Adjusted EBITDA offset by increased cash interest expense. Adjusted free cash flow in 2013 also benefited from the timing of maintenance capital expenditures related to approximately $12 million of equipment purchased at the end of 2013 and for which payment was not required until January 2014. As such, these items were not included in the Company's cash flows for 2013 but will increase its projected capital expenditures for 2014. |

|        |
|--------|
|        |  |  |
|   |   | 3 |

----

|        |
|--------|
|        |  |  |
|   |   | 4 |

----

|                                                                   |
|-------------------------------------------------------------------|
|                                                                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                              | For the Three Months Ended December 31, |   | For the Year Ended December 31, |
|                                                              | 2013 |   | 2012 |   | 2013 |   | 2012 |
|                                                              | (In Millions) |
| Net operating revenues                                            | $ | 572.1 |  |   | $ | 552.9 |  |   | $ | 2,273.2 |  |   | $ | 2,161.9 |  |
| Less:  Provision for doubtful accounts                            | (3.6 | ) |   | (7.2 | ) |   | (26.0 | ) |   | (27.0 | ) |
| Net operating revenues less provision for doubtful accounts       | 568.5 |  |   | 545.7 |  |   | 2,247.2 |  |   | 2,134.9 |  |
| Operating expenses:                                               |   |   |   |   |   |  |   |   |  |
| Salaries and benefits                                             | 272.0 |  |   | 269.5 |  |   | 1,089.7 |  |   | 1,050.2 |  |
| Other operating expenses                                          | 81.7 |  |   | 78.0 |  |   | 323.0 |  |   | 303.8 |  |
| Occupancy costs                                                   | 11.2 |  |   | 12.0 |  |   | 47.0 |  |   | 48.6 |  |
| Supplies                                                          | 27.1 |  |   | 26.2 |  |   | 105.4 |  |   | 102.4 |  |
| General and administrative expenses                               | 30.6 |  |   | 30.6 |  |   | 119.1 |  |   | 117.9 |  |
| Depreciation and amortization                                     | 25.2 |  |   | 21.7 |  |   | 94.7 |  |   | 82.5 |  |
| Government, class action, and related settlements                 | (0.2 | ) |   | — |  |   | (23.5 | ) |   | (3.5 | ) |
| Professional fees—accounting, tax, and legal                | 1.7 |  |   | 2.9 |  |   | 9.5 |  |   | 16.1 |  |
| Total operating expenses                                          | 449.3 |  |   | 440.9 |  |   | 1,764.9 |  |   | 1,718.0 |  |
| Loss on early extinguishment of debt                              | 2.4 |  |   | 2.7 |  |   | 2.4 |  |   | 4.0 |  |
| Interest expense and amortization of debt discounts and fees      | 26.5 |  |   | 24.3 |  |   | 100.4 |  |   | 94.1 |  |
| Other income                                                      | (1.3 | ) |   | (1.1 | ) |   | (4.5 | ) |   | (8.5 | ) |
| Equity in net income of nonconsolidated affiliates                | (3.0 | ) |   | (3.0 | ) |   | (11.2 | ) |   | (12.7 | ) |
| Income from continuing operations before income tax expense       | 94.6 |  |   | 81.9 |  |   | 395.2 |  |   | 340.0 |  |
| Provision for income tax expense                                  | 30.5 |  |   | 24.5 |  |   | 12.7 |  |   | 108.6 |  |
| Income from continuing operations                                 | 64.1 |  |   | 57.4 |  |   | 382.5 |  |   | 231.4 |  |
| Income (loss) from discontinued operations, net of tax            | 0.1 |  |   | 1.9 |  |   | (1.1 | ) |   | 4.5 |  |
| Net income                                                        | 64.2 |  |   | 59.3 |  |   | 381.4 |  |   | 235.9 |  |
| Less: Net income attributable to noncontrolling interests         | (15.3 | ) |   | (12.3 | ) |   | (57.8 | ) |   | (50.9 | ) |
| Net income attributable to HealthSouth                            | 48.9 |  |   | 47.0 |  |   | 323.6 |  |   | 185.0 |  |
| Less: Convertible perpetual preferred stock dividends             | (3.8 | ) |   | (5.8 | ) |   | (21.0 | ) |   | (23.9 | ) |
| Less: Repurchase of convertible perpetual preferred stock         | (71.6 | ) |   | — |  |   | (71.6 | ) |   | (0.8 | ) |
| Net (loss) income attributable to HealthSouth common shareholders | $ | (26.5 | ) |   | $ | 41.2 |  |   | $ | 231.0 |  |   | $ | 160.3 |  |

|        |
|--------|
|        |  |  |
|   | (Continued) | 5 |

----

|                                                                                              |
|----------------------------------------------------------------------------------------------|
|                                                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                         | For the Three Months Ended December 31, |   | For the Year Ended December 31, |
|                                                                                         | 2013 |   | 2012 |   | 2013 |   | 2012 |
|                                                                                         | (In Millions, Except per Share Data) |
| Weighted average common shares outstanding:                                                  |   |   |   |   |   |  |   |   |  |
| Basic                                                                                        | 86.4 |  |   | 94.7 |  |   | 88.1 |  |   | 94.6 |  |
| Diluted                                                                                      | 100.8 |  |   | 108.0 |  |   | 102.1 |  |   | 108.1 |  |
|                                                                                         |   |   |   |   |   |   |   |
| Basic and diluted (loss) earnings per share attributable to HealthSouth common shareholders: |   |   |   |   |   |  |   |   |  |
| Continuing operations                                                                        | $ | (0.31 | ) |   | $ | 0.41 |  |   | $ | 2.59 |  |   | $ | 1.62 |  |
| Discontinued operations                                                                      | — |  |   | 0.02 |  |   | (0.01 | ) |   | 0.05 |  |
| Net income                                                                                   | $ | (0.31 | ) |   | $ | 0.43 |  |   | $ | 2.58 |  |   | $ | 1.67 |  |
|                                                                                         |   |   |   |   |   |   |   |
| Cash dividends per common share                                                              | $ | 0.18 |  |   | $ | — |  |   | $ | 0.36 |  |   | $ | — |  |
|                                                                                         |   |   |   |   |   |   |   |
| Amounts attributable to HealthSouth:                                                         |   |   |   |   |   |  |   |   |  |
| Income from continuing operations                                                            | $ | 48.8 |  |   | $ | 45.1 |  |   | $ | 324.7 |  |   | $ | 180.5 |  |
| Income (loss) from discontinued operations, net of tax                                       | 0.1 |  |   | 1.9 |  |   | (1.1 | ) |   | 4.5 |  |
| Net income attributable to HealthSouth                                                       | $ | 48.9 |  |   | $ | 47.0 |  |   | $ | 323.6 |  |   | $ | 185.0 |  |

|        |
|--------|
|        |  |  |
|   |   | 6 |

----

|                                                                                             |
|---------------------------------------------------------------------------------------------|
|                                                                                             |  |  |  |  |  |  |  |
|                                                                                        | As of December 31, |
|                                                                                        | 2013 |   | 2012 |
|                                                                                        | (In Millions) |
| Assets                                                                                      |   |   |   |
| Current assets:                                                                             |   |   |   |
| Cash and cash equivalents                                                                   | $ | 64.5 |  |   | $ | 132.8 |  |
| Restricted cash                                                                             | 52.4 |  |   | 49.3 |  |
| Accounts receivable, net of allowance for doubtful accounts of $23.1 in 2013; $28.7 in 2012 | 261.8 |  |   | 249.3 |  |
| Deferred income tax assets                                                                  | 139.0 |  |   | 137.5 |  |
| Prepaid expenses and other current assets                                                   | 62.7 |  |   | 67.9 |  |
| Total current assets                                                                        | 580.4 |  |   | 636.8 |  |
| Property and equipment, net                                                                 | 910.5 |  |   | 748.0 |  |
| Goodwill                                                                                    | 456.9 |  |   | 437.3 |  |
| Intangible assets, net                                                                      | 88.2 |  |   | 73.2 |  |
| Deferred income tax assets                                                                  | 354.3 |  |   | 393.5 |  |
| Other long-term assets                                                                      | 144.1 |  |   | 135.4 |  |
| Total assets                                                                                | $ | 2,534.4 |  |   | $ | 2,424.2 |  |
| Liabilities and Shareholders’ Equity                                                  |   |  |   |   |  |
| Current liabilities:                                                                        |   |  |   |   |  |
| Current portion of long-term debt                                                           | $ | 12.3 |  |   | $ | 13.6 |  |
| Accounts payable                                                                            | 61.9 |  |   | 45.3 |  |
| Accrued payroll                                                                             | 90.8 |  |   | 85.7 |  |
| Accrued interest payable                                                                    | 23.8 |  |   | 25.9 |  |
| Other current liabilities                                                                   | 122.8 |  |   | 130.4 |  |
| Total current liabilities                                                                   | 311.6 |  |   | 300.9 |  |
| Long-term debt, net of current portion                                                      | 1,505.2 |  |   | 1,239.9 |  |
| Self-insured risks                                                                          | 98.2 |  |   | 106.5 |  |
| Other long-term liabilities                                                                 | 44.0 |  |   | 24.0 |  |
|                                                                                        | 1,959.0 |  |   | 1,671.3 |  |
| Commitments and contingencies                                                               |   |  |   |   |  |
| Convertible perpetual preferred stock                                                       | 93.2 |  |   | 342.2 |  |
| Redeemable noncontrolling interests                                                         | 13.5 |  |   | 7.2 |  |
| Shareholders’ equity:                                                                 |   |  |   |   |  |
| HealthSouth shareholders’ equity                                                      | 344.6 |  |   | 291.0 |  |
| Noncontrolling interests                                                                    | 124.1 |  |   | 112.5 |  |
| Total shareholders' equity                                                                  | 468.7 |  |   | 403.5 |  |
| Total liabilities and shareholders’ equity                                            | $ | 2,534.4 |  |   | $ | 2,424.2 |  |

|        |
|--------|
|        |  |  |
|   |   | 7 |

----

|                                                                                               |
|-----------------------------------------------------------------------------------------------|
|                                                                                               |  |  |  |  |  |  |  |
|                                                                                          | For the Year Ended December 31, |
|                                                                                          | 2013 |   | 2012 |
|                                                                                          | (In Millions) |
| Cash flows from operating activities:                                                         |   |   |   |
| Net income                                                                                    | $ | 381.4 |  |   | $ | 235.9 |  |
| Loss (income) from discontinued operations, net of tax                                        | 1.1 |  |   | (4.5 | ) |
| Adjustments to reconcile net income to net cash provided by operating activities — |   |  |   |   |  |
| Provision for doubtful accounts                                                               | 26.0 |  |   | 27.0 |  |
| Provision for government, class action, and related settlements                               | (23.5 | ) |   | (3.5 | ) |
| Depreciation and amortization                                                                 | 94.7 |  |   | 82.5 |  |
| Loss on early extinguishment of debt                                                          | 2.4 |  |   | 4.0 |  |
| Equity in net income of nonconsolidated affiliates                                            | (11.2 | ) |   | (12.7 | ) |
| Distributions from nonconsolidated affiliates                                                 | 11.4 |  |   | 11.0 |  |
| Stock-based compensation                                                                      | 24.8 |  |   | 24.1 |  |
| Deferred tax expense                                                                          | 6.4 |  |   | 102.7 |  |
| Other                                                                                         | 9.3 |  |   | 3.0 |  |
| (Increase) decrease in assets—                                                          |   |  |   |   |  |
| Accounts receivable                                                                           | (55.1 | ) |   | (51.3 | ) |
| Prepaid expenses and other assets                                                             | (4.8 | ) |   | 0.6 |  |
| Increase (decrease) in liabilities—                                                     |   |  |   |   |  |
| Accounts payable                                                                              | 6.4 |  |   | (4.4 | ) |
| Refunds due patients and other third-party payors                                             | (0.4 | ) |   | 2.7 |  |
| Other liabilities                                                                             | 5.0 |  |   | (5.7 | ) |
| Premium paid on redemption of bonds                                                           | (1.7 | ) |   | (1.9 | ) |
| Net cash (used in) provided by operating activities of discontinued operations                | (1.9 | ) |   | 2.0 |  |
| Total adjustments                                                                             | 87.8 |  |   | 180.1 |  |
| Net cash provided by operating activities                                                     | 470.3 |  |   | 411.5 |  |

|        |
|--------|
|        |  |  |
|   | (Continued) | 8 |

----

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |
|                                                                      | For the Year Ended December 31, |
|                                                                      | 2013 |   | 2012 |
|                                                                      | (In Millions) |
| Cash flows from investing activities:                                     |   |   |   |
| Purchases of property and equipment                                       | (195.2 | ) |   | (140.8 | ) |
| Capitalized software costs                                                | (21.3 | ) |   | (18.9 | ) |
| Acquisition of businesses, net of cash acquired                           | (28.9 | ) |   | (3.1 | ) |
| Proceeds from sale of restricted investments                              | 16.9 |  |   | 0.3 |  |
| Proceeds from sale of Digital Hospital                                    | 10.8 |  |   | — |  |
| Purchases of restricted investments                                       | (9.2 | ) |   | (9.1 | ) |
| Net change in restricted cash                                             | (3.1 | ) |   | (14.0 | ) |
| Other                                                                     | 0.5 |  |   | (0.9 | ) |
| Net cash provided by investing activities of discontinued operations      | 3.3 |  |   | 7.7 |  |
| Net cash used in investing activities                                     | (226.2 | ) |   | (178.8 | ) |
| Cash flows from financing activities:                                     |   |  |   |   |  |
| Proceeds from bond issuance                                               | — |  |   | 275.0 |  |
| Principal payments on debt, including pre-payments                        | (62.5 | ) |   | (166.2 | ) |
| Principal borrowings on notes                                             | 15.2 |  |   | — |  |
| Borrowings on revolving credit facility                                   | 197.0 |  |   | 135.0 |  |
| Payments on revolving credit facility                                     | (152.0 | ) |   | (245.0 | ) |
| Principal payments under capital lease obligations                        | (10.1 | ) |   | (12.1 | ) |
| Repurchase of common stock, including fees and expenses                   | (234.1 | ) |   | — |  |
| Repurchases of convertible perpetual preferred stock, including fees      | (2.8 | ) |   | (46.0 | ) |
| Dividends paid on common stock                                            | (15.7 | ) |   | — |  |
| Dividends paid on convertible perpetual preferred stock                   | (23.0 | ) |   | (24.6 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | (46.3 | ) |   | (49.3 | ) |
| Contributions from consolidated affiliates                                | 1.6 |  |   | 10.5 |  |
| Proceeds from exercising stock warrants                                   | 15.3 |  |   | — |  |
| Other                                                                     | 5.0 |  |   | (7.3 | ) |
| Net cash used in financing activities                                     | (312.4 | ) |   | (130.0 | ) |
| (Decrease) increase in cash and cash equivalents                          | (68.3 | ) |   | 102.7 |  |
| Cash and cash equivalents at beginning of year                            | 132.8 |  |   | 30.1 |  |
| Cash and cash equivalents at end of year                                  | $ | 64.5 |  |   | $ | 132.8 |  |

|        |
|--------|
|        |  |  |
|   |   | 9 |

----

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |
|                                                         | QTD |   |
|                                                         | Q4 2013 |   | Q4 2012 |   |
|                                                         | (In Millions, Except Per Share Data) |   |
| Adjusted EBITDA                                              | $ | 142.3 |  |   | $ | 128.6 |  |   |
| Interest expense and amortization of debt discounts and fees | (26.5 | ) |   | (24.3 | ) |   |
| Depreciation and amortization                                | (25.2 | ) |   | (21.7 | ) |   |
| Stock-based compensation expense                             | (5.8 | ) |   | (6.0 | ) |   |
| Noncash loss on disposal of assets                           | (1.6 | ) |   | (1.4 | ) |   |
|                                                         | 83.2 |  |   | 75.2 |  |   |
| Certain nonrecurring expenses:                               |   |   |   |   |
| Government, class action, and related settlements            | 0.2 |  |   | — |  |   |
| Professional fees—accounting, tax, and legal           | (1.7 | ) |   | (2.9 | ) |   |
| Loss on early extinguishment of debt                         | (2.4 | ) |   | (2.7 | ) |   |
| Pre-tax income                                               | 79.3 |  |   | 69.6 |  |   |
| Income tax expense (1)                                       | (30.5 | ) |   | (24.5 | ) |   |
| Income from continuing operations (2)                        | $ | 48.8 |  |   | $ | 45.1 |  |   |
|                                                         |   |   |   |   |
| Basic shares                                                 | 86.4 |  |   | 94.7 |  |   |
| Diluted shares                                               | 100.8 |  |   | 108.0 |  |   |
|                                                         |   |   |   |   |
| Basic (loss) earnings per share (2)(3)                       | $ | (0.31 | ) | (4)  | $ | 0.41 |  | (5)  |
| Diluted (loss) earnings per share (2)(3)                     | $ | (0.31 | ) | (4)  | $ | 0.41 |  | (5)  |

|           |                                                                                                                                                |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | Current income tax expense for the three months ended December 31, 2013 and 2012 was $3.3 million and $2.2 million, respectively. |

|           |                                                               |
|-----------|---------------------------------------------------------------|
| (2)  | Income from continuing operations attributable to HealthSouth |

|           |                                                                                                        |
|-----------|--------------------------------------------------------------------------------------------------------|
| (3)  | Diluted (loss) earnings per share are the same as basic (loss) earnings per share due to antidilution. |

|           |                                                                                                                                                                                           |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4)  | Includes an approximate $71.6 million, or $0.83 per basic share, negative impact resulting from the repurchase premium on the preferred stock in the November 2013 exchange transactions. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (5)  | In conjunction with the initiation of quarterly cash dividends in the third quarter of 2013, the Company revised its calculation to present earnings per share using the two-class method, which takes into consideration the impact of participating securities. Additional information regarding this revision and a computation of basic and diluted earnings per share can be found in Note 9, Earnings per Common Share, to the condensed consolidated financial statements included in Part I, Item 1, Financial Statements (Unaudited), of the Form 10-Q for the quarterly period ended September 30, 2013. |

|        |
|--------|
|        |  |  |
|   |   | 10 |

----

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |
|                                                         | YTD |   |
|                                                         | 2013 |   | 2012 |   |
|                                                         | (In Millions, Except Per Share Data) |   |
| Adjusted EBITDA                                              | $ | 551.6 |  |   | $ | 505.9 |  |   |
| Interest expense and amortization of debt discounts and fees | (100.4 | ) |   | (94.1 | ) |   |
| Depreciation and amortization                                | (94.7 | ) |   | (82.5 | ) |   |
| Stock-based compensation expense                             | (24.8 | ) |   | (24.1 | ) |   |
| Noncash loss on disposal of assets                           | (5.9 | ) |   | (4.4 | ) |   |
|                                                         | 325.8 |  |   | 300.8 |  |   |
| Certain nonrecurring expenses:                               |   |   |   |   |
| Government, class action, and related settlements            | 23.5 |  |   | 3.5 |  |   |
| Professional fees—accounting, tax, and legal           | (9.5 | ) |   | (16.1 | ) |   |
| Loss on early extinguishment of debt                         | (2.4 | ) |   | (4.0 | ) |   |
| Gain on consolidation of St. Vincent Rehabilitation Hospital | — |  |   | 4.9 |  |   |
| Pre-tax income                                               | 337.4 |  |   | 289.1 |  |   |
| Income tax expense (1)                                       | (12.7 | ) | (2)  | (108.6 | ) |   |
| Income from continuing operations (3)                        | $ | 324.7 |  |   | $ | 180.5 |  |   |
|                                                         |   |   |   |   |
| Basic shares                                                 | 88.1 |  |   | 94.6 |  |   |
| Diluted shares                                               | 102.1 |  |   | 108.1 |  |   |
|                                                         |   |   |   |   |
| Basic earnings per share (3)(4)                              | $ | 2.59 |  | (2)  | $ | 1.62 |  | (5)  |
| Diluted earnings per share (3)(4)                            | $ | 2.59 |  | (2)  | $ | 1.62 |  | (5)  |

|           |                                                                                                                                        |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | Current income tax expense for the year ended December 31, 2013 and 2012 was $6.3 million and $5.9 million, respectively. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)  | Includes an approximate $115 million, or $1.31 per basic share, benefit related to the Company's settlement with the IRS related to the previous restatement of its 2000 and 2001 financial statements, as well as certain other tax matters, through December 31, 2008. This earnings per share benefit was offset by a $71.6 million, or $0.81 per basic share, negative impact resulting from the repurchase premium on the preferred stock in the exchange transactions. |

|           |                                                               |
|-----------|---------------------------------------------------------------|
| (3)  | Income from continuing operations attributable to HealthSouth |

|           |                                                                                          |
|-----------|------------------------------------------------------------------------------------------|
| (4)  | Diluted earnings per share are the same as basic earnings per share due to antidilution. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (5)  | In conjunction with the initiation of quarterly cash dividends in the third quarter of 2013, the Company revised its calculation to present earnings per share using the two-class method, which takes into consideration the impact of participating securities. Additional information regarding this revision and a computation of basic and diluted earnings per share can be found in Note 9, Earnings per Common Share, to the condensed consolidated financial statements included in Part I, Item 1, Financial Statements (Unaudited), of the Form 10-Q for the quarterly period ended September 30, 2013. |

|        |
|--------|
|        |  |  |
|   |   | 11 |

----

|                                                                                     |
|-------------------------------------------------------------------------------------|
|                                                                                     |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                |   | For the Three Months Ended December 31, |   | For the Year Ended December 31, |
|                                                                                |   | 2013 |   | 2012 |   | 2013 |   | 2012 |
|                                                                                |   | (In Millions) |
| Net income                                                                          |   | $ | 64.2 |  |   | $ | 59.3 |  |   | $ | 381.4 |  |   | $ | 235.9 |  |
| (Income) loss from discontinued operations, net of tax, attributable to HealthSouth |   | (0.1 | ) |   | (1.9 | ) |   | 1.1 |  |   | (4.5 | ) |
| Provision for income tax expense                                                    |   | 30.5 |  |   | 24.5 |  |   | 12.7 |  |   | 108.6 |  |
| Interest expense and amortization of debt discounts and fees                        |   | 26.5 |  |   | 24.3 |  |   | 100.4 |  |   | 94.1 |  |
| Loss on early extinguishment of debt                                                |   | 2.4 |  |   | 2.7 |  |   | 2.4 |  |   | 4.0 |  |
| Professional fees—accounting, tax, and legal                                  |   | 1.7 |  |   | 2.9 |  |   | 9.5 |  |   | 16.1 |  |
| Government, class action, and related settlements                                   |   | (0.2 | ) |   | — |  |   | (23.5 | ) |   | (3.5 | ) |
| Net noncash loss on disposal or impairment of assets                                |   | 1.6 |  |   | 1.4 |  |   | 5.9 |  |   | 4.4 |  |
| Depreciation and amortization                                                       |   | 25.2 |  |   | 21.7 |  |   | 94.7 |  |   | 82.5 |  |
| Stock-based compensation expense                                                    |   | 5.8 |  |   | 6.0 |  |   | 24.8 |  |   | 24.1 |  |
| Net income attributable to noncontrolling interests                                 |   | (15.3 | ) |   | (12.3 | ) |   | (57.8 | ) |   | (50.9 | ) |
| Gain on consolidation of St. Vincent Rehabilitation Hospital                        |   | — |  |   | — |  |   | — |  |   | (4.9 | ) |
| Adjusted EBITDA                                                                     |   | $ | 142.3 |  |   | $ | 128.6 |  |   | $ | 551.6 |  |   | $ | 505.9 |  |

|        |
|--------|
|        |  |  |
|   |   | 12 |

----

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                      | For the Three Months Ended |   | For the Year Ended |
|                                                                      | December 31, |   | December 31, |
|                                                                      | 2013 |   | 2012 |   | 2013 |   | 2012 |
|                                                                      | (In Millions) |
| Net cash provided by operating activities                                 | $ | 100.9 |  |   | $ | 109.3 |  |   | $ | 470.3 |  |   | $ | 411.5 |  |
| Impact of discontinued operations                                         | 0.5 |  |   | (0.5 | ) |   | 1.9 |  |   | (2.0 | ) |
| Net cash provided by operating activities of continuing operations        | 101.4 |  |   | 108.8 |  |   | 472.2 |  |   | 409.5 |  |
| Capital expenditures for maintenance                                      | (20.5 | ) |   | (15.0 | ) |   | (74.8 | ) |   | (83.0 | ) |
| Dividends paid on convertible perpetual preferred stock                   | (5.8 | ) |   | (5.7 | ) |   | (23.0 | ) |   | (24.6 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | (12.2 | ) |   | (11.7 | ) |   | (46.3 | ) |   | (49.3 | ) |
| Nonrecurring items:                                                       |   |   |   |   |   |   |   |
| Premium paid on redemption of bonds                                       | 1.7 |  |   | 1.9 |  |   | 1.7 |  |   | 1.9 |  |
| Cash paid for:                                                            |   |   |   |   |   |   |   |
| Professional fees—accounting, tax, and legal                        | 1.7 |  |   | 2.9 |  |   | 7.0 |  |   | 16.1 |  |
| Government, class action, and related settlements                         | — |  |   | — |  |   | (5.9 | ) |   | (2.6 | ) |
| Adjusted free cash flow                                                   | $ | 66.3 |  |   | $ | 81.2 |  |   | $ | 330.9 |  |   | $ | 268.0 |  |

|        |
|--------|
|        |  |  |
|   |   | 13 |

----

|        |
|--------|
|        |  |  |
|   |   | 14 |